BackgroundTranscatheter aortic valve implantation (TAVI) was established as an important
alternative for high-risk patients with severe aortic stenosis. However, there are
few data in the literature regarding coronary obstruction, that although rare, is
a potentially fatal complication. ObjectiveEvaluate this complication in Brazil.MethodsWe evaluated all patients presenting coronary obstruction from the Brazilian
Registry of TAVI. Main baseline and procedural characteristics, management of the
complication, and clinical outcomes were collected from all patients.ResultsFrom 418 consecutive TAVI procedures, coronary obstruction occurred in 3 cases
(incidence of 0.72%). All patients were women, without prior coronary artery
bypass grafting (CABG), and with mean age of 85 ± 3 years, logistic EuroSCORE of
15 ± 6% and STS-PROM score of 9 ± 4%. All of the cases were performed with
balloon-expandable Sapien XT prosthesis. In one patient, with pre-procedural
computed tomography data, coronary arteries presented a low height and a narrow
sinus of Valsalva. All patients presented with clinically significant severe
maintained hypotension, immediately after valve implantation, and even though
coronary angioplasty with stent implantation was successfully performed in all
cases, patients died during hospitalization, being two periprocedurally.ConclusionCoronary obstruction following TAVI is a rare but potentially fatal complication,
being more frequent in women and with the balloon-expandable prosthesis.
Anatomical factors might be related with its increased occurrence, highlighting
the importance of a good pre-procedural evaluation of the patients in order to
avoid this severe complication.
Background:
Specific algorithms for use of optical coherence tomography (OCT) to guide percutaneous coronary intervention (PCI) are scarce. Also, the relative benefits of intravascular imaging guidance have not been tested against an optimized angiography-guided PCI strategy. In iSIGHT (Optical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions), we aimed to investigate whether OCT-guided PCI achieves noninferior stent expansion compared with intravascular ultrasound (IVUS) guidance and if both imaging modalities lead to superior stent expansion compared with an optimized angiography-based strategy.
Methods:
Patients ≥18 years old undergoing PCI for ≥1 lesion in native coronaries of 2.25 to 4.00 mm in diameter were randomized 1:1:1 to OCT-, IVUS-, or angiography-guided PCI. Predetermined guidance protocols were applied in all groups. An external elastic membrane–based protocol was used for stent sizing by OCT and IVUS. The primary end point was noninferiority of stent expansion (minimum stent area ≥90% of the average reference lumen area), measured by post-PCI OCT, in OCT-guided versus IVUS-guided PCI (noninferiority margin, 6.5%).
Results:
One hundred fifty-one patients (156 lesions) were randomly allocated to OCT (51 lesions [32.7%]), IVUS (52 lesions [33.3%]), or angiography (53 lesions [34.0%]). Stent expansion with OCT guidance (98.01±16.14%) was noninferior to IVUS (91.69±15.75%; 1-sided lower 95% CI, 0.55 mm
2
;
P
non-inferiority
<0.001) and superior to angiography (90.53±14.84%,
P
=0.041). IVUS and angiography obtained similar stent expansions (
P
=0.921). Stent edge dissection and periprocedural complication rates were not significantly different among the groups.
Conclusions:
Stent expansion with OCT guidance using a dedicated external elastic membrane–based sizing strategy was noninferior to that achieved with IVUS and superior to an optimized angiographic strategy.
REGISTRATION:
URL:
plataformabrasil.saude.gov.br
; Unique identifier: 69968417.8.0000.5462.
In very long term follow-up, more than 75% of patients exhibited sustained results. Prediction of late favorable results is multifactorial and strongly determined by age, previous symptoms and post-procedural mitral valve area.
The third-generation VES demonstrated excellent acute results in the treatment of de novo coronary lesions. Longer follow-up with a more complex subset of patients and lesions is required to confirm these preliminary results.
In this preliminary evaluation, the MGuard device demonstrated excellent performance in a highly complex lesion subset, including absence of angiographic/procedural complications, and no adverse events up to 30-day FU.
Análise da Incidência e Preditores Clínicos e Ecocardiográficos do Refluxo Paraprotético Aórtico após o Implante de Prótese Aórtica Transcateter Introdução: A incidência de refluxo paraprotético (RPP) parece maior entre os pacientes submetidos a implante de prótese aórtica transcateter e sua potencial associação com aumento da mortalidade tardia tem suscitado preocupação na comunidade científica. Nosso objetivo foi avaliar a incidência e o impacto clínico e estabelecer preditores do RPP em nossa casuística. Métodos: Entre julho de 2009 e fevereiro de 2013, 112 pacientes foram submetidos a implante de prótese aórtica transcateter. O grau do RPP pós-procedimento foi avaliado segundo os critérios do VARC 2. Dividiu-se a população em grupo RPP ausente/RPP discreto e grupo RPP moderado/RPP grave.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.